针对病毒性疾病的mRNA疗法的现状和前景
Qiuwei Pan1, Wenshi Wang2, Harry L A Janssen3,4
1Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands. q.pan@erasmusmc.nl.
由COVID-19疫苗验证的信使RNA (mRNA) 治疗方法现在正在扩展到新的抗病毒治疗方法. 这些先进的mRNA策略为对抗病毒性疾病和改善流行病准备提供了新的希望.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 病毒性疾病对全球健康和经济造成重大负担.
- 使者RNA (mRNA) 技术已经成为一个强大的平台,特别是在COVID-19疫苗取得成功后.
- mRNA应用的范围正在迅速扩大,超越疫苗,包括直接抗病毒疗法.
研究的目的:
- 审查mRNA治疗病毒感染的最新进展.
- 以突出新兴的基于mRNA的策略来打击病毒性疾病.
- 确定挑战,并为mRNA治疗开发和全球卫生安全提出解决方案.
主要方法:
- 对治疗病毒感染的mRNA疗法进行的临床前和临床研究的审查.
- 对新兴策略的分析,包括抗体表达,免疫效应物传递和基于CRISPR的系统.
- 讨论mRNA传递技术的进展.
主要成果:
- 在疫苗之外的各种抗病毒应用中,mRNA疗法显示出希望.
- 新兴的策略包括体内抗体生产,免疫刺激剂输送和基因编辑方法.
- 交付系统的进步促进了临床翻译,尽管挑战仍然存在.
结论:
- mRNA技术是开发新型抗病毒疗法的通用平台.
- 解决稳定性,特异性和免疫性方面的挑战对于临床成功至关重要.
- 针对mRNA疗法的战略开发对于控制流行性病毒性疾病和加强流行病准备是必不可少的.
更多相关视频
06:19Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
08:33Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
Published on: February 28, 2016
相关概念视频
Regulated mRNA Transport
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Nuclear Export of mRNA
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
